156 related articles for article (PubMed ID: 26547056)
1. Structure-activity relationship studies of pyrimidine-2,4-dione derivatives as potent P2X7 receptor antagonists.
Park JH; Lee GE; Lee SD; Ko H; Kim YC
Eur J Med Chem; 2015 Dec; 106():180-93. PubMed ID: 26547056
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells.
Kwak SH; Shin S; Lee JH; Shim JK; Kim M; Lee SD; Lee A; Bae J; Park JH; Abdelrahman A; Müller CE; Cho SK; Kang SG; Bae MA; Yang JY; Ko H; Goddard WA; Kim YC
Eur J Med Chem; 2018 May; 151():462-481. PubMed ID: 29649742
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships and optimization of 3,5-dichloropyridine derivatives as novel P2X(7) receptor antagonists.
Lee WG; Lee SD; Cho JH; Jung Y; Kim JH; Hien TT; Kang KW; Ko H; Kim YC
J Med Chem; 2012 Apr; 55(8):3687-98. PubMed ID: 22400713
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel purine-based heterocyclic P2X7 receptor antagonists.
Kwak SH; Lee WG; Lee YJ; Lee SD; Kim YC; Ko H
Bioorg Chem; 2015 Aug; 61():58-65. PubMed ID: 26123174
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel 2,5-dioxoimidazolidine-based P2X(7) receptor antagonists as constrained analogues of KN62.
Park JH; Lee GE; Lee SD; Hien TT; Kim S; Yang JW; Cho JH; Ko H; Lim SC; Kim YG; Kang KW; Kim YC
J Med Chem; 2015 Mar; 58(5):2114-34. PubMed ID: 25597334
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X7 receptor.
Baraldi PG; del Carmen Nuñez M; Morelli A; Falzoni S; Di Virgilio F; Romagnoli R
J Med Chem; 2003 Apr; 46(8):1318-29. PubMed ID: 12672232
[TBL] [Abstract][Full Text] [Related]
7. P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinones.
de Luna Martins D; Borges AA; E Silva NADA; Faria JV; Hoelz LVB; de Souza HVCM; Bello ML; Boechat N; Ferreira VF; Faria RX
Bioorg Chem; 2020 Nov; 104():104278. PubMed ID: 33010623
[TBL] [Abstract][Full Text] [Related]
8. Discovery, synthesis and SAR of azinyl- and azolylbenzamides antagonists of the P2X₇ receptor.
Subramanyam C; Duplantier AJ; Dombroski MA; Chang SP; Gabel CA; Whitney-Pickett C; Perregaux DG; Labasi JM; Yoon K; Shepard RM; Fisher M
Bioorg Med Chem Lett; 2011 Sep; 21(18):5475-9. PubMed ID: 21782426
[TBL] [Abstract][Full Text] [Related]
9. 1,4-Naphthoquinones potently inhibiting P2X7 receptor activity.
Faria RX; Oliveira FH; Salles JP; Oliveira AS; von Ranke NL; Bello ML; Rodrigues CR; Castro HC; Louvis AR; Martins DL; Ferreira VF
Eur J Med Chem; 2018 Jan; 143():1361-1372. PubMed ID: 29133043
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and in vitro Evaluation of P2X7 Antagonists.
T Pournara D; Durner A; Kritsi E; Papakostas A; Zoumpoulakis P; Nicke A; Koufaki M
ChemMedChem; 2020 Dec; 15(24):2530-2543. PubMed ID: 32964578
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of carboxylic acid derivatives of pyridoxal as P2X receptor antagonists.
Jung KY; Cho JH; Lee JS; Kim HJ; Kim YC
Bioorg Med Chem; 2013 May; 21(9):2643-50. PubMed ID: 23510563
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 2.
Brumfield S; Matasi JJ; Tulshian D; Czarniecki M; Greenlee W; Garlisi C; Qiu H; Devito K; Chen SC; Sun Y; Bertorelli R; Ansell J; Geiss W; Le VD; Martin GS; Vellekoop SA; Haber J; Allard ML
Bioorg Med Chem Lett; 2011 Dec; 21(24):7287-90. PubMed ID: 22078214
[TBL] [Abstract][Full Text] [Related]
13. Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535.
Duplantier AJ; Dombroski MA; Subramanyam C; Beaulieu AM; Chang SP; Gabel CA; Jordan C; Kalgutkar AS; Kraus KG; Labasi JM; Mussari C; Perregaux DG; Shepard R; Taylor TJ; Trevena KA; Whitney-Pickett C; Yoon K
Bioorg Med Chem Lett; 2011 Jun; 21(12):3708-11. PubMed ID: 21565499
[TBL] [Abstract][Full Text] [Related]
14. Novel Series of Dihydropyridinone P2X7 Receptor Antagonists.
Lopez-Tapia F; Walker KA; Brotherton-Pleiss C; Caroon J; Nitzan D; Lowrie L; Gleason S; Zhao SH; Berger J; Cockayne D; Phippard D; Suttmann R; Fitch WL; Bourdet D; Rege P; Huang X; Broadbent S; Dvorak C; Zhu J; Wagner P; Padilla F; Loe B; Jahangir A; Alker A
J Med Chem; 2015 Nov; 58(21):8413-26. PubMed ID: 26460788
[TBL] [Abstract][Full Text] [Related]
15. Escape from adamantane: Scaffold optimization of novel P2X7 antagonists featuring complex polycycles.
Barniol-Xicota M; Kwak SH; Lee SD; Caseley E; Valverde E; Jiang LH; Kim YC; Vázquez S
Bioorg Med Chem Lett; 2017 Feb; 27(4):759-763. PubMed ID: 28126517
[TBL] [Abstract][Full Text] [Related]
16. Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists.
Rudolph DA; Alcazar J; Ameriks MK; Anton AB; Ao H; Bonaventure P; Carruthers NI; Chrovian CC; De Angelis M; Lord B; Rech JC; Wang Q; Bhattacharya A; Andres JI; Letavic MA
Bioorg Med Chem Lett; 2015 Aug; 25(16):3157-63. PubMed ID: 26099534
[TBL] [Abstract][Full Text] [Related]
17. Substituted 5,6-(Dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 Antagonists.
Ziff J; Rudolph DA; Stenne B; Koudriakova T; Lord B; Bonaventure P; Lovenberg TW; Carruthers NI; Bhattacharya A; Letavic MA; Shireman BT
ACS Chem Neurosci; 2016 Apr; 7(4):498-504. PubMed ID: 26754558
[TBL] [Abstract][Full Text] [Related]
18. Piperazine squaric acid diamides, a novel class of allosteric P2X7 receptor antagonists.
Patberg M; Isaak A; Füsser F; Ortiz Zacarías NV; Vinnenberg L; Schulte J; Michetti L; Grey L; van der Horst C; Hundehege P; Koch O; Heitman LH; Budde T; Junker A
Eur J Med Chem; 2021 Dec; 226():113838. PubMed ID: 34571173
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Pharmacological Evaluation of Novel Non-nucleotide Purine Derivatives as P2X7 Antagonists for the Treatment of Neuroinflammation.
Calzaferri F; Narros-Fernández P; de Pascual R; de Diego AMG; Nicke A; Egea J; García AG; de Los Ríos C
J Med Chem; 2021 Feb; 64(4):2272-2290. PubMed ID: 33560845
[TBL] [Abstract][Full Text] [Related]
20. 8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages.
Pacheco PAF; Galvão RMS; Faria AFM; Von Ranke NL; Rangel MS; Ribeiro TM; Bello ML; Rodrigues CR; Ferreira VF; da Rocha DR; Faria RX
Bioorg Med Chem; 2019 Apr; 27(8):1449-1455. PubMed ID: 30528164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
